ContractWarrant Agreement • July 29th, 2015 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR, SUBJECT TO SECTION 11 HEREOF, AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL) REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT, OR ANY APPLICABLE STATE SECURITIES LAWS.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 29th, 2015 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
This Stock Purchase Agreement (“Agreement”) is made and entered into on July 28, 2015 (“Effective Date”), by and between Immune Pharmaceuticals Inc., a Delaware corporation (“Company”), and the investor whose name appears on the signature page hereto (“Investor”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • July 29th, 2015 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LOAN AND SECURITY AGREEMENT is made and dated as of July 29, 2015 and is entered into by and between IMMUNE PHARMACEUTICALS INC., a Delaware corporation and IMMUNE PHARMACEUTICALS USA CORP., and each of their subsidiaries (hereinafter collectively with the exception of Guarantor referred to as the “Borrower”), IMMUNE PHARMACEUTICALS LTD., (“Guarantor”) the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent for itself and the Lender (in such capacity, the “Agent”).
Form of Voting Agreement VOTING AGREEMENTVoting Agreement • July 29th, 2015 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Voting Agreement (“Agreement”) is made and entered into on July __, 2015 (“Effective Date”), by and between the stockholder (“Stockholder”) of Immune Pharmaceuticals Inc., a Delaware corporation (“Company”) whose name appears on the signature page hereto, and the investor (“Investor”) in Company whose name appears on the signature page hereto.
